PeeVee.TV
   

  ログイン

ホーム 新規ユーザー登録

新着動画一覧

01

サムネイル

GenVec (GNVC) Extends Research Collaboration with Novartis

CRWENewswire, Stocks to Watch. GenVec Inc - GNVC - reported that it has extended its Research Collaboration and License Agreement with Novartis. Under the extension, Novartis will fund research at GenVec through January 2013 to support its hearing loss and balance disorders program. In January 2010, GenVec entered into a worldwide licensing and collaboration agreement with Novartis to discover and develop novel treatments for hearing loss and balance disorders. According to the company, under the terms of the agreement, if certain clinical, regulatory, and sales milestones are met, GenVec is eligible to receive up to $213.6 million, including upfront and milestone payments in addition to royalties on future sales. GenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. ********* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! (Read Full Disclaimer at http://www.crwenewswire.com/disclaimer)

投稿者:サイト名 karmastock
投稿日時:2012.1.29. 15:50
視聴回数:321回
お気に入り登録:0
カテゴリ: ビジネス全般  
タグ: Novartis   GenVec   GNVC   NASDAQ:GNVC  

01

   
videovar
iPeeVee iPeeVee

会社概要 |  ソリューション |  お問い合わせ |  スタッフ募集 |  利用規約 |  プライバシーポリシー

Copyright (C) 2006-2020 PeeVee Corporation. All rights reserved.